Drug

MK-6240 clinical trials

studies test it: 3
open now: 1
in phase 3: 0
first study started: 2016

Keep track of what changes. Save the MK-6240 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Development codes

MK-6240: 1

Studies by the year they started

2 studies that test it; most in 2016 (1); 1 more planned to start later

Studies that test MK-6240, by start year
Year	Studies
2016	1
2020	1

By phase

A phase 1/2 study counts in both.

Early Phase 1: 1
Phase 1: 2

What it is tested for

Each study’s main condition, where its own words name it.

Alzheimer Disease: 3

Who runs them

Industry 1 · Other 2

Genentech, Inc. (1) · Invicro (1) · Columbia University (1)

Often tested with

Tested in the same studies.

Izaflortaucipir F-18 (1) · Sulfur Hexafluoride (1) · Florbetapir (1) · Gadoterate meglumine (1)

Studies

Open first, then newest update. How each study uses MK-6240 is read from its arms, and is right about nine times in ten.